Other clients included Ennex International, Consolidated Puma Minerals (a separately-listed offshoot of Bema), Zincox and European Minerals. He was responsible for securing, among other assets, the Varvarinskoye copper-gold project for European Minerals.
Dr Kurzin spent months in Moscow negotiating for licenses and arranging that dollars raised from gold sales could remain in London. He says: “We did much pioneering work – for example, we won the first waiver from Gokhran (the Russian state treasury) to allow a mining company to sell gold and silver directly to commercial banks rather than to the central bank. “The financing of Julietta was eventually completed in 2000. Dr Kurzin points out that Julietta was one of only three gold projects in the world financed that year.
Bema also owns 75% of the Kupol gold project in Russia’s Chukotka region. Dr Kurzin says he learned about Kupol, discovered in 1995, from a Gokhran contact.
At first, Bema could not believe how high the grades are at Kupol. The company now reckons Kupol should be in production in mid-2008, with scheduled annual output of 550,000 oz of gold and 5.8 Moz of silver, at an all-in cash cost of US$88/oz for the gold, over a mine life of six-and-a-half years.
In 2004, Dr Kurzin was invited by Stephen Dattels, an entrepreneur who was previously involved in several natural-resources projects, to join Oriel Resources. “I took a week to decide because I was pretty comfortable doing my consulting work,” Dr Kurzin recalls.
Oriel listed on London’s AIM market in March 2004, after raising more than £40 million, and on Toronto’s TSX Venture Exchange in February last year. After Oriel was listed, Mr Dattels resigned for personal reasons, and Dr Kurzin is now the company’s executive chairman.
It has not been a completely happy experience so far. Shares in Oriel, sold at the listing for £0.65/share, lost more than half their market value. But recently they have recovered strongly. Dr Kurzin says: “If I was starting out again, I would do it differently. There were mistakes.”
He assembled a portfolio of five properties for Oriel, and is focusing on two projects in particular: Voskhod chrome and Shevchenko nickel, both in Kazakhstan.
The Voskhod project, which Dr Kurzin describes as “one of the best chrome projects on the planet”, is now being fast-tracked instead of Shevchenko.
The latter, a “robust” nickel project, would cost about US$594 million to build, a sum that Dr Kurzin is unwilling to finance at a time when Oriel’s share price is low. Instead, Oriel is looking for a partner to form a joint venture at Shevchenko.
Oriel’s gold exploration projects are to be spun off into a separate, listed company, Lero Gold, which has raised C$5 million and in which Oriel will be a 60% shareholder.
There is, says Dr Kurzin, a great deal of behind-the-scenes activity going on in Oriel that he can’t yet discuss. But he promises “shareholders will be pleased” when all is revealed.
Dr Kurzin’s latest venture, Everfor Diamonds, listed on AIM on April 6. He says that when he was working on Puma’s projects, it became clear Russia’s Kola Peninsula had never been properly explored for diamonds while having all the geological indications that they might be present there.
So, in 2000, he hired Don Duncan, who had spent 25 years with De Beers exploring for, and mining, diamonds on three continents, to look at the Kola area.
“De Beers, Rio Tinto and BHPB are showing big interest in Kola now. But they are having difficulties getting licenses so far. We raised money privately – £3 million – to buy a Russian company that already had four licenses and to complete two years of extensive aero-geophysics and sampling work that was analysed in South African laboratories,” says Dr Kurzin.
Everfor raised £1.63 million ahead of its listing and “that allows us two years of aggressive exploration. So far we have identified about 40 priority drilling targets.”
Dr Kurzin and his family own 10 million Oriel shares, when options are included, and 8 million Everfor shares. The value of these stakes at present comes nowhere near the market value of his 5 million shares in UrAsia Energy, one of the world’s four listed uranium producers, now trading at more than C$3/share on the TSX Venture Exchange.
UrAsia is the brainchild of Frank Guistra, chairman of Endeavour Financial and a long-standing contact of Dr Kurzin’s. So, when UrAsia’s financial adviser, Canaccord, asked Dr Kurzin to help out, he had no hesitation.
He says: “I helped with the negotiations [in Kazakhstan]. I helped different mentalities from different cultures to understand one another.” UrAsia’s annualised production from its 70% interest in the Akdala in-situ leach mine in Kazakhstan is an estimated 1.4 Mlb of uranium oxide. Dr Kurzin now favours Kazakhstan more than Russia for his projects.
He says: “It is very much easier to work in a smaller country where you can find the right people and get the right answers.
ENDS
